We are happy to announce that registrations are now open* for Penta‘s new interactive training programme – ‘PentaTr@ining: AMR Online Course’! This timely course brings together doctors, nurses, pharmacists and other healthcare workers linked through the...

We are pleased to have reached the two-thirds recruitment milestone with more than 750 children admitted to hospital with severe or very severe pneumonia, now recruited into the PediCAP trial. The last couple of years have been particularly challenging for our trial...

The PediCAP consortium is pleased to announce a major milestone. Site teams in Uganda, Zambia, Zimbabwe and South Africa have successfully reached 50% recruitment of the PediCAP trial. Of the 1100 expected participants of children hospitalised with severe or very...

We are pleased to announce that we have successfully passed our 25% recruitment milestone with more than 400 patients successfully randomised into their arms. The PediCAP trial will determine whether children hospitalised for severe or very severe pneumonia, do better...

The recent GRAM report on the global impact of antimicrobial resistance highlights the ongoing challenges to antibiotic stewardship. Considering global assessments of antibiotic use patterns, it is essential to note that children are likely to have an approximately three times higher consumption of antibiotics than adults in most settings, regardless of country income level

On February 24th, 2022, the PediCAP consortium met for a general assembly meeting. The general assembly meeting is the main meeting in which all consortium members and work package leaders within the PediCAP project meet to share progress, address issues and make key...

At the end of 2021, LAB-Net provided training on the sampling and microbiology procedures to all five sites taking part in the microbiology sub-study in the Paediatric Community Acquired Pneumonia (PediCAP) project.   Microbiologists, technicians and study...

The PediCAP health economics analysis team presented preliminary results of an analysis to estimate the global consumption and costs of two commonly used antibiotics for managing childhood infections in community settings: amoxicillin and co-amoxiclav. Both are...